Evidence map›Paper›PMID 39195743›Full record

ArticleToxins2024

Molecular Screening for Cyanobacteria and Their Cyanotoxin Potential in Diverse Habitats.

Maša Jablonska, Tina Eleršek, Polona Kogovšek, Sara Skok, Andreea Oarga-Mulec, Janez Mulec

Abstract read
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maša JablonskaDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, 1000 Ljubljana, Slovenia.ORCID 0000-0003-1988-3600
Tina EleršekDepartment of Genetic Toxicology and Cancer Biology, National Institute of Biology, 1000 Ljubljana, Slovenia.ORCID 0000-0003-3296-3808
Polona KogovšekDepartment of Biotechnology and Systems Biology, National Institute of Biology, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4035-0115
Sara SkokKarst Research Institute, Research Centre of the Slovenian Academy of Sciences and Arts, 6230 Postojna, Slovenia.ORCID 0000-0002-8475-0815
Andreea Oarga-MulecMaterials Research Laboratory, University of Nova Gorica, 5000 Nova Gorica, Slovenia.ORCID 0000-0002-0885-8429
Janez MulecKarst Research Institute, Research Centre of the Slovenian Academy of Sciences and Arts, 6230 Postojna, Slovenia.ORCID 0000-0003-1687-1479

Funding

Slovenian Research Agency P6-0119, P1-0245, P4-0407, P2-0412, project funding J2-4428, and Young researcher grant number 10040146 (MZ)
6 · The paper itself

Abstract

Cyanobacteria are adaptable and dominant organisms that exist in many harsh and extreme environments due to their great ecological tolerance. They produce various secondary metabolites, including cyanotoxins. While cyanobacteria are well studied in surface waters and some aerial habitats, numerous other habitats and niches remain underexplored. We collected 61 samples of: (i) biofilms from springs, (ii) aerial microbial mats from buildings and subaerial mats from caves, and (iii) water from borehole wells, caves, alkaline, saline, sulphidic, thermal, and iron springs, rivers, seas, and melted cave ice from five countries (Croatia, Georgia, Italy, Serbia, and Slovenia). We used (q)PCR to detect cyanobacteria (phycocyanin intergenic spacer-PC-IGS and cyanobacteria-specific 16S rRNA gene) and cyanotoxin genes (microcystins-

Indexed as

CyanobacteriaEcosystemBacterial ToxinsBiofilmsCavesCroatiaCyanobacteria ToxinsEnvironmental MonitoringItalyMicrocystinsRNA, Ribosomal, 16SSerbiaSloveniaWater MicrobiologyBacterial ToxinsCyanobacteria ToxinsMicrocystinsRNA, Ribosomal, 16Scavescylindrospermopsinextreme environmentsPC-IGSqPCRsulphidic springs

Identifiers

PMID39195743
PMCPMC11360522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.